MiNK Therapeutics INKT
NASDAQ INKT
$10.83 +0.77 (+7.62%)
As of: Oct 23, 2026 · 3:54 PM EDT

MiNK Therapeutics (INKT) Revenue (2021 - 2026)

Updated

Analysis

MiNK Therapeutics (INKT) Revenue (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 25.40 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 16.99 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 15.03 Bn
10 MiNK Therapeutics 54.42 Mn 13.23 Mn - 72,884.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 72,884.00
Mar 31, 2026 80,834.00
Dec 31, 2025 111,230.00
Sep 30, 2025 55,151.00
Jun 30, 2025 348.00
Mar 31, 2025 13,517.00
Dec 31, 2024 39,573.00
Sep 30, 2024 78,015.00
Jun 30, 2024 38,360.00
Mar 31, 2024 16,619.00
Dec 31, 2023 41,525.00
Sep 30, 2023 107,287.00
Jun 30, 2023 146,389.00
Mar 31, 2023 168,055.00
Dec 31, 2022 134,835.00
Sep 30, 2022 92,960.00
Jun 30, 2022 26,377.00
Mar 31, 2022 -848.00
Dec 31, 2021 -1,547.00
Sep 30, 2021 -881,323.00
API Access

MiNK Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=INKT&period=max&api_key=YOUR_API_KEY